How Often Should You Get Breast Implants Replaced?

Your breast implants aren’t lifetime devices. Understand their longevity, what to look for, and the considerations for updating them over time.

Breast implants do not come with a fixed expiration date, and there is no universal rule that they must be swapped out every ten years. That “ten-year rule” is one of the most persistent myths in cosmetic and reconstructive surgery. The reality is more individual: implants are not lifetime devices, and most people will need at least one revision over a lifetime, but the timing depends on how the implant holds up, how your body responds to it, and what screening reveals along the way.

Why the Ten-Year Rule Is Misleading

The idea that implants expire after a decade likely stems from older manufacturer warranty periods and FDA language noting that breast implants are not meant to last forever. That language is accurate in spirit but gets distorted into a countdown clock. In practice, rupture rates are initially very low and begin to climb meaningfully after about six to eight years. Some implants last well beyond fifteen or twenty years without problems. Others develop issues within five. The decision to replace is driven by what is happening with a specific implant inside a specific person, not by the calendar alone.

That said, the longer an implant is in place, the higher the chance that something will eventually prompt a revision. Capsular contracture, rupture, changes in breast shape, and patient dissatisfaction all accumulate over time. Thinking of replacement as an if-and-when decision rather than a scheduled one is closer to how most surgeons approach it today.

How Implants Fail

Implant failure looks different depending on whether you have silicone gel or saline devices, but both types can develop problems that make replacement or removal the right call.

With silicone implants, the most common failure mode is a shell rupture that allows gel to leak. The most frequent cause of rupture is actually instrument damage during the original placement surgery, though shell fatigue over years of compression and folding also contributes. The tricky part is that silicone ruptures are often “silent.” In most cases, the leaked gel stays trapped inside the scar capsule your body has formed around the implant, so you might not notice anything visually or by touch. In a smaller number of cases, gel escapes that capsule, which can cause local tissue inflammation and granuloma formation. The recommended course when a silicone rupture is confirmed is removal, to prevent gel from triggering ongoing inflammatory reactions.

Saline implants fail differently and more obviously. When the shell develops a tear or the valve fails, the sterile saltwater inside leaks out and is absorbed by the body. The breast visibly deflates, sometimes over hours, sometimes gradually over weeks. Mechanical folding of the shell is one documented cause: repeated creasing in the same spot can eventually wear through, producing a microscopic tear. Because the deflation is hard to miss, saline failures are essentially self-diagnosing, which is one advantage over silicone in terms of knowing when it is time to act.

Capsular Contracture and Why It Drives Most Revisions

Your body naturally forms a thin layer of scar tissue around any implanted device. When that capsule stays soft and flexible, you do not notice it. But in some people, the capsule tightens and hardens over time, squeezing the implant. This is capsular contracture, and it ranges from barely detectable firmness to visible distortion and pain.

Capsular contracture has been the leading reason for breast implant reoperation for decades. A German study examining nearly a thousand revision cases found it was the most common finding before both implant removal and implant replacement surgeries. One meta-analysis of women reporting breast implant illness found capsular contracture rates of about 44% and implant rupture rates of roughly 21% among those patients, underscoring how closely the two issues travel together.

If capsular contracture is mild, you and your surgeon might decide to monitor rather than operate. But when it progresses to noticeable hardness, shape change, or discomfort, revision surgery is the standard approach. During revision, the surgeon removes or partially removes the tightened capsule and replaces the implant. Capsulectomy is not always mandatory in the absence of symptoms or pathologic findings, though any suspicion of capsular disease warrants it.

FDA Screening Recommendations

Because silicone ruptures can be invisible to you and your doctor on physical exam, imaging plays a central role in knowing whether your implants are intact. In 2020, the FDA updated its surveillance recommendations: for silicone implants, you should get an ultrasound or MRI five to six years after placement, then every two to three years after that. For anyone who develops symptoms at any point, such as pain, swelling, or changes in shape, imaging is recommended right away rather than waiting for the next scheduled check.

MRI has traditionally been considered the gold standard for detecting silicone rupture. A meta-analysis of diagnostic studies estimated MRI sensitivity at about 87% and specificity at about 90%. More recent work, however, suggests that high-quality ultrasound performed by experienced radiologists may come closer to MRI than previously thought, with one study reporting sensitivity around 95% and specificity around 96%. Ultrasound is cheaper, faster, and more accessible, which matters when you are looking at a screening schedule that spans decades. Still, MRI remains recommended for ambiguous ultrasound findings or symptomatic patients.

For saline implants, routine imaging is less critical since deflation is clinically obvious. Regular physical exams and mammograms remain important, but the silent-rupture concern that drives the FDA’s screening timeline largely applies to silicone devices.

BIA-ALCL and Textured Implants

One relatively rare but serious concern that has changed the replacement conversation is breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL. This is not breast cancer; it is a type of lymphoma that develops in the scar capsule around the implant. A systematic review of epidemiological studies found that every confirmed case of BIA-ALCL has involved a history of textured-surface implants. Not a single case has been reported in someone who only ever had smooth implants.

The absolute risk remains low, but if you currently have textured implants and are considering replacement, switching to smooth devices is a discussion worth having with your surgeon. When textured implants are being exchanged for smooth ones, en bloc capsulectomy (removing the entire capsule as a single piece) is reserved for cases where BIA-ALCL has been diagnosed, while in asymptomatic patients a less aggressive capsule approach can be reasonable.

Breast Implant Illness

Breast implant illness, often called BII, refers to a collection of systemic symptoms that some people with implants develop. Fatigue, joint pain, and muscle pain are the most commonly reported complaints, appearing on average about six years after implantation. The condition does not have a single agreed-upon diagnostic test, and researchers are still working out the underlying mechanisms. Microbial biofilm on the implant surface, chronic low-grade capsular inflammation, and individual immune responses are among the proposed contributors.

What the data do show consistently is that the majority of patients who choose explantation for BII report improvement. A large meta-analysis found roughly 82% of patients reported symptom improvement after having their implants removed. A prospective cohort study found significant decreases in all measured symptom scores after explantation, along with improvements in quality of life and breast satisfaction. If you have implants and are dealing with unexplained fatigue, widespread pain, or cognitive fog, BII is worth considering as a possible cause, and explantation is a legitimate option rather than a fringe idea.

When Your Body Changes Around the Implant

Even when an implant is perfectly intact and your capsule is soft, your body is not static. Breast tissue changes with hormonal shifts, pregnancy, breastfeeding, weight fluctuations, aging, and gravity. Over ten or twenty years, you might develop ptosis (sagging) that leaves the implant sitting high while the natural tissue falls below it, or significant weight loss might make an implant look disproportionately large. These cosmetic shifts are a common reason people seek revision even without a medical complication.

These changes are not a failure of the implant itself but a normal part of how your body evolves around a static device. Some people pursue a straightforward size or profile swap. Others opt for a lift combined with new implants. And increasingly, some choose to remove implants entirely and address volume or shape through other means.

Choosing Removal Over Replacement

Not everyone who has implants removed wants new ones put in. Whether the motivation is BII symptoms, fatigue with the maintenance cycle, or a simple change in aesthetic preference, permanent explantation is increasingly common. The concern many people have is what their breasts will look like afterward, especially if they have had implants for a long time and the tissue has stretched.

One approach that has gained traction is combining implant removal with a breast lift and fat grafting. Fat is harvested from another area of the body via liposuction and transferred to the breast to restore some volume and improve contour. Studies on this combined technique report satisfactory aesthetic results and strong patient-reported outcomes. Another approach, auto-augmentation mastopexy, reshapes the existing breast tissue during the lift to create a fuller appearance without implants, sometimes combined with fat grafting for additional volume.

Research looking specifically at patient satisfaction after explantation with a simultaneous lift showed significant improvement across physical well-being, psychological well-being, sexual well-being, and breast appearance. Among those who reported BII symptoms, about 88% noted reduced pain, muscle and joint aches, and fatigue after surgery. In another long-term single-center study, over 80% of patients reported lasting satisfaction following implant removal or revision.

What Revision Surgery Actually Involves

If you do decide to replace rather than remove, revision surgery is more complex than the initial augmentation. The surgeon has to address the existing capsule, potentially change the implant pocket, and manage tissue that has been stretched or thinned over years. Complications after secondary implant surgery can be challenging, and the stakes are somewhat higher than for a first-time procedure because the tissue has already been operated on.

Decisions that come up during revision include whether to perform a full capsulectomy (removing the entire scar capsule), whether to switch implant types or sizes, and whether to change from above the chest muscle to below it or vice versa. A full capsulectomy adds surgical time and carries additional risk of bleeding and tissue damage, so for patients with no symptoms and no capsular pathology, some surgeons opt for a partial capsulectomy or capsule scoring instead. On the other hand, anyone with signs of BIA-ALCL, significant contracture, or capsular pathology needs complete capsule removal.

Recovery from revision is generally similar to the initial surgery, though tissue handling can be more delicate the second time around. Most surgeons recommend the same activity restrictions: limited upper body movement for several weeks, avoidance of heavy lifting, and gradual return to exercise.

Modern Implants and Whether They Last Longer

Today’s implants are not the same devices that were placed twenty years ago. Shell technology has improved, gel formulations have become more cohesive, and manufacturers offer a wider range of profiles. A recent comparative study testing multiple current-generation silicone devices found meaningful differences in gel stability, shell strength, and overall form retention across brands. More form-stable gels, for instance, are designed to hold their shape better and potentially slow the migration of silicone if a shell breach occurs.

Whether these engineering improvements translate into fewer replacements over a lifetime is still an open question. The devices simply have not been in patients long enough to generate the thirty-year data that would settle it definitively. What can be said is that newer implants rupture less frequently in the short and medium term than older generations did. If you are getting implants for the first time today, you are likely starting with a more durable device than what was available a decade or two ago. But “more durable” is not the same as “permanent,” and the same body-driven factors like capsular contracture and tissue changes still apply regardless of which generation of implant you have.

A Practical Approach to Timing

Rather than watching the calendar for a replacement date, the most evidence-supported approach is a combination of regular self-monitoring, scheduled imaging, and check-ins with a board-certified plastic surgeon. A reasonable framework looks like this:

  • Daily awareness: Notice changes in shape, firmness, size asymmetry, or new pain. Saline deflation is obvious; silicone issues can be subtler.
  • Annual check-ups: A physical exam by your surgeon or a physician familiar with implant assessment.
  • Imaging at five to six years: Ultrasound or MRI per FDA guidance, then every two to three years.
  • Prompt evaluation: Any new symptoms like unexplained fatigue, persistent pain, swelling, or hardness warrant imaging and a surgical consult without waiting for the next scheduled screen.

If imaging shows an intact implant and you have no symptoms, there is no medical reason to replace a functioning device just because a certain number of years have passed. The replacement conversation starts when something changes: a confirmed rupture, progressive contracture, cosmetic dissatisfaction, systemic symptoms suggestive of BII, or a desire to switch implant types. Until then, you monitor, you stay informed, and you leave the surgery for when it is actually needed.